TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic and Episodic HeadacheHeadache Disorders

PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE

Eligible age

18–60 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Headache, in its episodic and chronic forms, cannot be considered solely as an isolated neurological symptom, but as a complex condition of a bio-psycho-social nature. While in the episodic form the painful episodes occur intermittently and have a variable impact on daily life, in the chronic form the disease evolves towards persistent pain, with more significant consequences on personal, social and work functioning. The following study protocol aims to investigate in an integrated manner the neurological, cognitive and psychological mechanisms involved in headache, with particular attention to the differences between episodic and chronic forms. The main objective is to assess the neuropsychological profiles and pain response of patients, monitoring their evolution over a period of approximately six months, considering the impact of central sensitisation, personality structure and any psychopathological comorbidities on pain management and treatment adherence. The protocol adopts a multidimensional approach aimed at optimising therapeutic efficacy and improving patients' quality of life, preventing progression to chronicity.

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo

You may qualify if…

  • Age between 18 and 60 years;
  • Diagnosis of chronic or episodic headache;
  • Patients attending the Headache Outpatient Clinic.

You may not qualify if…

  • Presence of severe psychiatric and neurological disorders;
  • Presence of oncological diseases in terminal stage

Source: ClinicalTrials.gov · NCT07268768 · last updated 2025-12-08

PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATIO · TrialPath